Abstract:Objective: To investigate the effect of intrathecal δ-opioid receptor antagonists specificity on morphine tolerance in rats with chronic pain,and to explore possible mechanism of morphine tolerance.Methods: Sprague-Dawley rats were successfully modeled with bone cancer pain or spared nerve injury(SNI),and then intrathecal catheters were placed in.The animals were randomly divided into eight groups: bone cancer pain +saline group(group BC),bone cancer pain +morphine group(group BM),bone cancer pain +naltrindole +morphine group(group BN),bone cancer pain +DPDPE +morphine group(group BD),SNI +saline group(group SC),SNI +morphine group(group SM),SNI +naltrindole +morphine group(group SN),SNI +DPDPE +morphine group(group SD).Rats in each group began to give medicine ten days after pain models were made.Group BC/SC and group BM/SM rats were accepted intrathecal injection(I.T.) of saline and 10 μg morphine which dissolved in 10 μl saline,respectively.In group BN/SN,intrathecal morphine 10 μg/10 μl was given 20 minutes after intrathecal naltrindole 10 μg/10 μl was administered,while rats in group BD/SD were accepted intrathecal DPDPE 1 μg/10 μl at first,and then intrathecal morphine 10 μg/10 μl was injected 20 minutes later.All SNI model rats were injected twice a day for 9 consecutive days,while bone cancer model rats were injected three times a day for 9 consecutive days.The mechanical allodynia was measured respectively at baseline and 3,5,7,9 days(T3,T5,T7,T9) after SNI or bone cancer pain model operation and 1,4,7,9 days(I1,I4,I7,I9) during injection of drugs.Heart perfusion by 4% paraformaldehyde was performed in the implantation rats after the last injection of drugs.Then bilateral tibias of rats were sliced into frozen sections and stained with H-E.Results: H-E stain showed that cells of the implantation tibia had absolutely pleomorphism and the bone defects were extensive.The bone cancer pain model was successful.All animals successfully developed nociceptive hypersensitivity after cancer cell inoculations or SNI operations,and the paw withdrawal threshold significantly reduced(P < 0.05).The paw withdrawal threshold of each group except group BC/SC had a significant increase and revealed that morphine had analgesic action during medication(P < 0.05).But the paw withdrawal threshold measured at I7,I9 was significantly lower than that at I1(P < 0.05).In bone cancer model rats,rats in group BM had lower paw withdrawal threshold compared to that in group BN at I9(P < 0.05).In SNI model,the paw withdrawal threshold in group SM and group SD was significantly lower than that in group SN at I7 and I9(P < 0.05).Conclusion: Intrathecally-administered specific δ-opioid receptor antagonist(naltrindole),can restrain morphine tolerance.These results suggest that δ-opioid receptor may be involved in the formation of morphine tolerance.

Effect and Mechanism of Opioid Receptor Antagonist on Allograft Rejection

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Pharmacological Characterization of the Opioid Inactive Isomers (+)-Naltrexone and (+)-Naloxone As Toll-Like Receptor 4 Antagonists

The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception

Design, synthesis, and biological evaluation of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as μ opioid receptor selective Antagonists

Decreased percentages of regulatory T cells are necessary to activate Th1-Th17-Th22 responses during acute rejection of the peripheral nerve xenotransplantation in mice

A Novel MyD88 Inhibitor Attenuates Allograft Rejection after Heterotopic Tracheal Transplantation in Mice

Effect of intrathecal δ-opioid receptor antagonists specificity on morphine tolerance in rats with chronic pain

Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats

Neurotoxin from Naja naja atra venom inhibits skin allograft rejection in rats

Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection.

Modulation of Intrathecal Morphine-Induced Immunosuppression by Microinjection of Naloxone into Periaqueductal Gray

Effect and Mechanisms of Transplantation Tolerance Induced by Donor Natural Killer T Cells(NKT) Infused Intravenously

The Relationship of Indoleamine 2, 3-Dioxygenase Gene Expression and Acute Immune Rejection after Rat Liver Transplantation

IMMUNE MODULATION AND PREVENTION OF ALLOGENEIC GRAFT REJECTION BY THERAPEUTIC DENDRITIC CELLS:

Transgenic increase in the β-endorphin concentration in cerebrospinal fluid alleviates morphine-primed relapse behavior through the μ opioid receptor in rats.

Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects

Opioid Antagonists Naloxone, Β-Funaltrexamine and Naltrindole, but Not Nor-Binaltorphimine, Reverse the Increased Hindpaw Withdrawal Latency in Rats Induced by Intrathecal Administration of the Calcitonin Gene-Related Peptide Antagonist CGRP8–37

Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery

Interferon-Alpha Reinstates Morphine-Conditioned Place Preference Through Opioid Receptors in Rats